| MR编号 | AT/H/0343/001 |
|---|
| 药品名称 | Feiba 500 E. Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
|---|
| 活性成分 | - FACTOR VIII INHIBITOR BYPASSING FRACTION 500.0 E
|
|---|
| 剂型 | Powder and solvent for solution for injection |
|---|
| 上市许可持有人 | Baxter AG
Industriestrasse 67
A-1221 Vienna |
|---|
| 参考成员国 - 产品名称 | Austria (AT) FEIBA 500 E. Pulver und Lösungsmittel zur Herstellung einer Infusionslösung |
|---|
| 互认成员国 - 产品名称 | - Malta (MT)
FEIBA 25 U/ml powder and solvent for solution for infusion - Latvia (LV)
Feiba 25 V/ml pulveris un šķīdinātājs infūziju šķīduma pagatavošanai - Greece (GR)
- Slovenia (SI)
- Netherlands (NL)
Feiba 25E/ml - Czechia (CZ)
Feiba NF 25 U/ml prášek a rozpouštědlo pro injekční/infuzní roztok - Lithuania (LT)
- Bulgaria (BG)
- Cyprus (CY)
- Romania (RO)
FEIBA 25 U/ml pulbere şi solvent pentru soluţie perfuzabilă
|
|---|
| 许可日期 | 2009/12/11 |
|---|
| 最近更新日期 | 2024/08/28 |
|---|
| 药物ATC编码 | - B02BD03 factor VIII inhibitor bypassing activity
| 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4：Biological: Blood Product
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|